Christopher J. Centeno

Regenexx is a pioneer in the field of interventional orthopedics and regenerative medicine, specializing in non-surgical treatments for musculoskeletal conditions. Founded by Dr. Christopher Centeno, the company developed a patented protocol for using a patient's own bone marrow-derived stem cells and blood platelets to treat orthopedic injuries. They operate an extensive global network of physician clinics that utilize standardized laboratory processing and precise, image-guided injection techniques. Their approach serves as an alternative to traditional orthopedic surgeries for conditions such as joint arthritis, spinal disc pain, and ligament tears. The company maintains one of the world's largest human databases for regenerative orthopedic outcomes, emphasizing a data-driven approach to patient care.